摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trimethyl{[4-(propan-2-yloxy)phenyl]ethynyl}silane | 877603-48-0

中文名称
——
中文别名
——
英文名称
trimethyl{[4-(propan-2-yloxy)phenyl]ethynyl}silane
英文别名
4-isopropoxy-1-(2-trimethylsilyl-1-ethynyl)benzene;Trimethyl-[2-(4-propan-2-yloxyphenyl)ethynyl]silane
trimethyl{[4-(propan-2-yloxy)phenyl]ethynyl}silane化学式
CAS
877603-48-0
化学式
C14H20OSi
mdl
——
分子量
232.398
InChiKey
DNOFNACKVNXFIY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    trimethyl{[4-(propan-2-yloxy)phenyl]ethynyl}silane四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 反应 4.5h, 以71%的产率得到1-乙炔基-4-异丙氧基苯
    参考文献:
    名称:
    [EN] NOVEL HETEROCYCLIC AMIDE DERIVATIVES HAVING DIHYDROOROTATE DEHYDROGENASE INHIBITING ACTIVITY
    [FR] NOUVEAUX DERIVES D'AMIDES HETEROCYCLIQUES AYANT UNE ACTIVITE D'INHIBITION DE LA DIHYDROOROTATE DESHYDROGENASE
    摘要:
    This invention provides a novel cyclic amide derivative with pharmacological activity. The compound of the present invention is a compound represented by the following general formula (1) or a salt thereof. In the formula, X1-X2 is S-CH2, etc.; R1 is an alkyl group, etc.; p is 0-7; R2 is hydrogen, alkyl, etc.; R3 is hydrogen, alkyl group, etc.; Y1-Y2 is CH=CH, etc.; R4 is halogen, alkyl group, etc.; q is 0-4; R5 represents halogen, hydrogen, alkyl group, etc.
    公开号:
    WO2006022442A1
  • 作为产物:
    描述:
    4-碘苯酚 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodidepotassium carbonate三乙胺三苯基膦 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 4.0h, 生成 trimethyl{[4-(propan-2-yloxy)phenyl]ethynyl}silane
    参考文献:
    名称:
    Halogen Bonding of (Iodoethynyl)benzene Derivatives in Solution
    摘要:
    Halogen bonding (XB) between (iodoethynyl)benzene donors and quinuclidine in benzene affords binding free enthalpies (ΔG, 298 K) between -1.1 and -2.4 kcal mol(-1), with a strong LFER with the Hammett parameter σpara. The enthalpic driving force is compensated by an unfavorable entropic term. The binding affinity of XB acceptors increases in the order pyridine < C═O < S═O < P═O < quinuclidine. Diverse XB packing motifs are observed in the solid state.
    DOI:
    10.1021/ol502099j
点击查看最新优质反应信息

文献信息

  • Synthesis of poly(1-chloro-2-arylacetylene)s with high cis-content and examination of their absorption/emission properties
    作者:Jesus Rodriguez Castanon、Natsuhiro Sano、Masashi Shiotsuki、Fumio Sanda
    DOI:10.1002/pola.28397
    日期:2017.2.1
    A series of 1‐chloro‐2‐arylacetylenes [Cl‐CC‐Ar, Ar = C6H5 (1), C6H4‐p‐iPr (2), C6H4‐p‐OiPr (3), C6H4‐p‐NHC(O)OtBu (4), and C6H4‐o‐iPr (5)] were polymerized using (tBu3P)PdMeCl/silver trifluoromethanesulfonate (AgOTf) and MoCl5/SnBu4 catalysts. The corresponding polymers [poly(1)–poly(5)] with weight‐average molecular weights of 6,500–690,000 were obtained in 10–91% yields. THF‐insoluble parts, presumably
    一系列1--2-芳基乙炔[Cl-CC-Ar,Ar = C 6 H 5(1),C 6 H 4 - p - i Pr(2),C 6 H 4 - p- O我PR(3),C 6 H ^ 4 - p -NHC(O)O吨卜(4),和C 6 H ^ 4 - ö -我PR(5)]使用聚合(TBU 3P)PdMeCl /三氟甲磺酸(AgOTf)和MoCl 5 / SnBu 4催化剂。重均分子量为6,500-690,000的相应聚合物[poly(1)-poly(5)]以10-91%的产率获得。通过Pd催化的聚合反应,与THF可溶性聚合物一起形成了不溶于THF的部分,可能是高分子聚合物。Pd催化剂聚合非极性单体1和2的产率低于Mo催化剂,而Pd催化剂聚合极性单体3和4的产率较高的相应聚合物。在1聚合物的1 H NMR和UV-vis吸收光谱表明,Pd基聚合物的顺式含量高于Mo基聚合物,而Pd基聚合物的共轭长
  • Synthesis and Antiplasmodial Activity of New Indolone <i>N</i>-Oxide Derivatives
    作者:Françoise Nepveu、Sothea Kim、Jeremie Boyer、Olivier Chatriant、Hany Ibrahim、Karine Reybier、Marie-Carmen Monje、Severine Chevalley、Pierre Perio、Barbora H. Lajoie、Jalloul Bouajila、Eric Deharo、Michel Sauvain、Rachida Tahar、Leonardo Basco、Antonella Pantaleo、Francesco Turini、Paolo Arese、Alexis Valentin、Eloise Thompson、Livia Vivas、Serge Petit、Jean-Pierre Nallet
    DOI:10.1021/jm901300d
    日期:2010.1.28
    A series of 66 new indolone-N-oxide derivatives was synthesized with three different methods. Compounds were evaluated for in vitro activity against CQ-sensitive (3D7), CQ-resistant (FcB1), and CQ and pyrimethamine cross-resistant (K1) strains of Plasmodium falciparum (P.f.), its well as for cytotoxic concentration (CC50) on MCF7 and KB human tumor Cell lines. Compound 26 (5-methoxy-indolone-N-oxide analogue) had the most potent antiplasmodial activity in vitro (< 3 nM on FcB1 and = 1.7 nM on 3D7) with a very satisfactory selectivity index (CC50 MCF7/IC50 FcB1: 14623; CC50 KB/IC50 3D7: 198823). In in vivo experiments, compound 1 (dioxymethylene derivatives of the indolone-N-oxide) showed the best antiplasmodial activity against Plasmodium berghei, 62% inhibition of the parasitaemia at 30 mg/kg/day.
  • 2-Aryl-3H-indol-3-ones: Synthesis, electrochemical behaviour and antiplasmodial activities
    作者:Ennaji Najahi、Alexis Valentin、Paul-Louis Fabre、Karine Reybier、Françoise Nepveu
    DOI:10.1016/j.ejmech.2014.03.059
    日期:2014.5
    The synthesis of indolone derivatives and their antiplasmodial activity in vitro against Plasmodium falciparum at the blood stage are described. The 2-aryl-3H-indol-3-ones were synthesized via deoxygenation of indolone-N-oxides. Electrochemical behaviour, antiplasmodial activity and cytotoxicity on human tumor cell lines were compared to those of indolone-N-oxides. The antiplasmodial IC50 (concentrations at 50% inhibition) of these compounds ranged between 49 and 1327 nM. Among them, the 2(4-dimethylaminophenyl)-5-methoxy-indol-3-one, 7, had the best antiplasmodial activity in vitro (IC50 = 49 nM; FcB1 strain) and selectivity index (SI (CC50 MCF7/IC50 FcB1) = 423.4). Thus, the hits identified in this deoxygenated series correspond to their structural homologs in the N-oxide series with comparable electrochemical behaviour at the nitrogen-carbon double bond. (C) 2014 Elsevier Masson SAS. All rights reserved.
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯